Project Number GDAPB-201801-2014627 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2019 View Full Project Details for Validation of a rapid non-invasive diagnostic test to predict mild cognitive impairment and early Alzheimer’s disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers b. Blood-based Biomarkers Researcher and Organization Principal Investigator Moussaoui, Saliha Principal Investigator First Name Saliha Principal Investigator Last Name Moussaoui Awardee Organization Amoneta Diagnostics Contact PI Country France Project Detail Funding Opportunity Announcement Diagnostics Accelerator: Peripheral Biomarkers RFP FY Overall Cost $2,000,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
